NASDAQ · Biotechnology

Compugen Ltd. (CGEN) Stock

$2.12 -1.40% NASDAQ: CGEN Healthcare

Valuation

MetricValue
Price$2.12
Market Cap$200.45M
P/E Ratio6.15
P/B Ratio2.46
P/S Ratio2.95
EPS (TTM)$0.38
52-Week High$3.24
52-Week Low$1.43
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE42.57%
ROA25.43%
ROCE26.18%
Gross Margin43.84%
Operating Margin42.47%
Net Margin47.55%
Debt/Equity0.03
Current Ratio6.43

Annual Financials (USD)

Metric20212022202320242025
Revenue$6.0M$8.0M$33.0M$28.0M$73.0M
Operating Profit$-35.0M$-35.0M$-13.0M$-15.0M$31.0M
Net Profit$-34.0M$-34.0M$-19.0M$-14.0M$35.0M
EPS$-0.41$-0.39$-0.21$-0.16$0.38
Op Margin-584.6%-471.6%-38.8%-53.4%43.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$132.0M$94.0M$121.0M$115.0M$157.0M
Total Liabilities$25.0M$16.0M$56.0M$60.0M$54.0M
Cash$8.0M$11.0M$14.0M$18.0M$91.0M
Borrowings$3.0M$2.0M$1.0M$3.0M$3.0M

Latest News

Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress PR Newswire · Jun 18, 2026 Compugen (CGEN) Stock Faces Mixed Analyst Target Changes After Cautious Valuation Revisions Simply Wall St. · Jun 18, 2026 Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026 PR Newswire · Jun 11, 2026 Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development PR Newswire · Jun 8, 2026 Why The Narrative Around Compugen (NasdaqCM:CGEN) Is Shifting After Analyst Resets And New Views Simply Wall St. · Jun 3, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-23.0M$-34.0M$-36.0M$50.0M$32.0M
Investing Cash Flow$6.0M$37.0M$35.0M$-46.0M$30.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$1.0M$3.0M$3.0M$4.0M$72.0M
Free Cash Flow$-23.0M$-35.0M$-36.0M$49.0M$31.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.07
EV / EBITDA5.99
FCF Yield0.00%
Quick Ratio5.72
Interest Coverage0.00
Return 1Y49.04%
Return 3Y108.93%
Return 5Y-66.33%

Ownership

Insiders Held2.08%
Institutions Held15.42%
Institutions Float Held15.75%
Institutional HolderSharesReport Date
SilverArc Capital Management, LLC3,315,8452026-03-31
Renaissance Technologies, LLC1,632,9882026-03-31
Morgan Stanley1,053,2292026-03-31
ARK Investment Management, LLC1,049,8732026-03-31
Nomura Asset Management International Inc1,020,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $340.42 +1.11% 38.93 $5.00T 0.32%
MSFTMicrosoft Corporation $522.61 -1.35% 28.68 $3.88T 0.76%
GOOGLAlphabet Inc. $348.29 -0.63% 16.94 $4.22T 0.26%
AMZNAmazon.com, Inc. $254.06 -2.25% 19.82 $2.73T 0.00%
METAMeta Platforms, Inc. $720.89 -0.06% 27.93 $1.84T 0.28%

About Compugen Ltd.

Compugen Ltd. is led by CEO Eran Ophir, employs 74 people, headquartered in IL, publicly traded since 2000.

Compugen Ltd. (CGEN) stock trades at $2.12 with a market capitalization of $200.45M. The stock is valued at a price-to-earnings (P/E) ratio of 6.15, price-to-book of 2.46, price-to-sales of 2.95. Over the past 52 weeks the stock has ranged between $1.43 and $3.24, and currently trades 34.6% below its 52-week high.

On profitability, Compugen Ltd. generates a return on equity (ROE) of 42.57% — well above the market average, a sign of a high-quality business, return on capital employed of 26.18%, an operating margin of 42.47%, a net profit margin of 47.55%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides